The use of botulinum toxin a in idiopathic overactive bladder syndrome

Christopher S. Gomez, Prashanth Kanagarajah, Angelo Gousse

Research output: Contribution to journalReview articlepeer-review

9 Scopus citations


Overactive bladder syndrome continues to be a significant burden for the general population. Current first-line medical therapy often includes antimuscarinic medications designed for overactive bladder. Poor efficacy and significant side effects of these antimuscarinic medications have left patients and physicians looking for alternative treatments. There is increasing evidence that intradetrusor injection of botulinum toxin A can effectively treat these patients. We present a current and extensive review of the literature covering the use of botulinum toxin A in patients with overactive bladder with or without idiopathic detrusor overactivity.

Original languageEnglish (US)
Pages (from-to)353-359
Number of pages7
JournalCurrent urology reports
Issue number5
StatePublished - Sep 2010


  • Botox
  • Botulinum toxin A
  • Dysport
  • Idiopathic detrusor overactivity
  • Idiopathic overactive bladder
  • Overactive bladder syndrome

ASJC Scopus subject areas

  • Urology


Dive into the research topics of 'The use of botulinum toxin a in idiopathic overactive bladder syndrome'. Together they form a unique fingerprint.

Cite this